4//SEC Filing
Gold Mark Stephen 4
Accession 0000805928-21-000113
CIK 0000805928other
Filed
Jun 2, 8:00 PM ET
Accepted
Jun 3, 5:15 PM ET
Size
11.7 KB
Accession
0000805928-21-000113
Insider Transaction Report
Form 4
Axogen, Inc.AXGN
Gold Mark Stephen
Director
Transactions
- Exercise/Conversion
Common Stock
2021-06-01+6,173→ 302,439 total - Award
Stock Option (right to buy)
2021-06-01+6,030→ 6,030 totalExercise: $19.76Exp: 2031-06-01→ Common Stock (6,030 underlying) - Award
Restricted Stock Units
2021-06-01+3,036→ 3,036 total→ Common Stock (3,036 underlying) - Exercise/Conversion
Restricted Stock Units
2021-06-01−6,173→ 0 total→ Common Stock (6,173 underlying)
Footnotes (4)
- [F1]The shares of common stock for Dr. Gold include 159,575 shares held jointly by Dr. Gold and his wife, indirect ownership of 22,000 shares held by Dr. Gold's spouse in revocable trusts, and indirect ownership of 92,000 shares held by MJSK, Ltd., a decedent investment trust.
- [F2]Each restricted stock unit represents a contingent right to receive one share of Axogen, Inc. common stock.
- [F3]This reflects the number of restricted stock units that became vested as of June 1, 2021.
- [F4]Annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The number of shares pursuant to the equity grant is based on a $120,000 valuation as of the grant date and vests on June 1, 2022, one year from the anniversary of the grant date. One-half of the annual equity grant value is in the form of non-qualified stock options and one-half of the annual equity grant value is in the form of restricted stock units.
Documents
Issuer
Axogen, Inc.
CIK 0000805928
Entity typeother
Related Parties
1- filerCIK 0001531332
Filing Metadata
- Form type
- 4
- Filed
- Jun 2, 8:00 PM ET
- Accepted
- Jun 3, 5:15 PM ET
- Size
- 11.7 KB